As of May 2021, Moderna's share price decreased by seven percent as a reaction to the U.S. support of the WTO's proposed temporary waiver of COVID-19 vaccine patents. This statistic illustrates the early share price reaction of COVID-19 vaccine makers to U.S. support of temporarily wavering COVID-19 vaccine patents.
Early share price reaction of COVID-19 vaccine makers to U.S. support of temporarily wavering patents as of May, 2021
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Evaluate Vantage. (May 6, 2021). Early share price reaction of COVID-19 vaccine makers to U.S. support of temporarily wavering patents as of May, 2021 [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/1236248/market-reaction-covid-vaccine-makers-to-us-support-of-vaccine-patents-waiver/
Evaluate Vantage. "Early share price reaction of COVID-19 vaccine makers to U.S. support of temporarily wavering patents as of May, 2021." Chart. May 6, 2021. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/1236248/market-reaction-covid-vaccine-makers-to-us-support-of-vaccine-patents-waiver/
Evaluate Vantage. (2021). Early share price reaction of COVID-19 vaccine makers to U.S. support of temporarily wavering patents as of May, 2021. Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/1236248/market-reaction-covid-vaccine-makers-to-us-support-of-vaccine-patents-waiver/
Evaluate Vantage. "Early Share Price Reaction of Covid-19 Vaccine Makers to U.S. Support of Temporarily Wavering Patents as of May, 2021." Statista, Statista Inc., 6 May 2021, https://www.statista.com/statistics/1236248/market-reaction-covid-vaccine-makers-to-us-support-of-vaccine-patents-waiver/
Evaluate Vantage, Early share price reaction of COVID-19 vaccine makers to U.S. support of temporarily wavering patents as of May, 2021 Statista, https://www.statista.com/statistics/1236248/market-reaction-covid-vaccine-makers-to-us-support-of-vaccine-patents-waiver/ (last visited November 21, 2024)
Early share price reaction of COVID-19 vaccine makers to U.S. support of temporarily wavering patents as of May, 2021 [Graph], Evaluate Vantage, May 6, 2021. [Online]. Available: https://www.statista.com/statistics/1236248/market-reaction-covid-vaccine-makers-to-us-support-of-vaccine-patents-waiver/
